Birchview Capital, LP

Holdings History for Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	4.8%	+0.93%	$8,252,400	260,000	+50,000	+24%	$31.74	Q4 2025
30 Sep 2025	3.7%	0%	$4,935,000	210,000	0		$23.50	Q3 2025
30 Jun 2025	2.4%	-0%	$2,383,500	210,000	-5	-0%	$11.35	Q2 2025
31 Mar 2025	1.2%	+0%	$1,396,533	210,005	+5		$6.65	Q1 2025
31 Dec 2024	1.9%	0%	$2,316,300	210,000	0		$11.03	Q4 2024
30 Sep 2024	2.2%	0%	$2,580,900	210,000	0		$12.29	Q3 2024
30 Jun 2024	2.6%	0%	$2,837,100	210,000	0		$13.51	Q2 2024
31 Mar 2024	2.3%	0%	$2,835,000	210,000	0		$13.50	Q1 2024
31 Dec 2023	0.86%	+0.52%	$1,104,600	210,000	+125,000	+147%	$5.26	Q4 2023
30 Sep 2023	0.28%	0%	$334,900	85,000	0		$3.94	Q3 2023
30 Jun 2023	0.68%	+0.56%	$903,550	85,000	+70,000	+467%	$10.63	Q2 2023
31 Mar 2023	0.1%	0%	$125,000	15,000	0		$8.33	Q1 2023
31 Dec 2022	0.1%	0%	$138,000	15,000	0		$9.20	Q4 2022
30 Sep 2022	0.14%	0%	$193,000	15,000	0		$12.87	Q3 2022
30 Jun 2022	0.14%	0%	$198,000	15,000	0		$13.20	Q2 2022
31 Mar 2022	0.23%	0%	$316,000	15,000	0		$21.07	Q1 2022
31 Dec 2021	0.23%	0%	$360,000	15,000	0		$24.00	Q4 2021
30 Sep 2021	0.26%	0%	$382,000	15,000	0		$25.47	Q3 2021
30 Jun 2021	0.31%	0%	$505,000	15,000	0		$33.67	Q2 2021
31 Mar 2021	0.35%	-0.12%	$583,000	15,000	-5,000	-25%	$38.87	Q1 2021
31 Dec 2020	0.72%	0%	$1,239,000	20,000	0		$61.95	Q4 2020
30 Sep 2020	0.45%	0%	$670,000	20,000	0		$33.50	Q3 2020
30 Jun 2020	0.29%	0%	$477,000	20,000	0		$23.85	Q2 2020
31 Mar 2020	0.41%	+0.41%	$458,000	20,000	+20,000	NEW	$22.90	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.